MedTrace Logo

A Pilot Study to Assess the Effect of Intermittent iNO on the Treatment of NTM Lung Infection in CF and Non-CF Patients

NCT04685720 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2022-12-16

No results posted yet for this study

Summary

The purpose of this open-label, multicenter, non-randomized, pilot study is to assess the safety of high dose intermittent iNO for treatment of NTM infection in CF and non-CF patients.

Conditions

  • Non-Tuberculous Mycobacterial Pneumonia
  • Cystic Fibrosis
  • Mycobacterial Pneumonia
  • Mycobacterium Abscessus Infection
  • Mycobacterium Avium Complex

Interventions

DEVICE

LungFit

LungFit for NTM is an experimental device that produces Nitric Oxide from the ambient air.

Sponsors & Collaborators

  • Beyond Air Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-07
Primary Completion
2022-07-28
Completion
2022-10-10

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04685720 on ClinicalTrials.gov